Evelo Biosciences Inc. (EVLO)

0.00

-0.00 (-100.00%)

At close: Feb 27, 2025, 3:00 PM

0.32

12536.00%

After-hours: Dec 11, 2023, 06:46 PM EST

Evelo Biosciences Cash Flow Statement

Table Mode

Year	FY22	FY21	FY20	FY19	FY18	FY17	FY16
Net Income	-114.53M	-122.18M	-93.67M	-85.47M	-56.95M	-28.05M	-13.33M
Depreciation & Amortization	2.06M	2.22M	2.03M	1.76M	1.94M	834K	495K
Stock-Based Compensation	15.16M	15.85M	8.47M	8.16M	6.06M	1.54M	419K
Other Working Capital	-9.84M	1.91M	6.93M	4.06M	1.39M	1.3M	99K
Other Non-Cash Items	5.74M	2.1M	2.35M	255K	103K	35K	28K
Deferred Income Tax	n/a	3.22M	-6K	-166K	406K	301K	20K
Change in Working Capital	-9.67M	2.07M	7.76M	3.47M	1.16M	2.07M	56K
Operating Cash Flow	-101.23M	-96.72M	-73.06M	-71.98M	-47.28M	-23.27M	-12.31M
Capital Expenditures	-622K	-1.52M	-1.32M	-3.03M	-5.46M	-1.74M	-1.25M
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	10.49M
Purchase of Investments	n/a	n/a	n/a	n/a	-136.09M	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	55M	81.25M	n/a	n/a
Other Investing Acitivies	n/a	38K	6K	2K	171K	n/a	27K
Investing Cash Flow	-622K	-1.48M	-1.31M	51.97M	-60.13M	-1.74M	9.26M
Debt Repayment	-3.12M	14.78M	10M	4.48M	4.97M	n/a	7M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	234K	1.01M	471K	511K	81.21M	48.97M	8.74M
Financial Cash Flow	81.66M	97.54M	65.47M	4.99M	162.01M	48.97M	15.74M
Net Cash Flow	-20.66M	-666K	-8.91M	-15.02M	54.6M	23.96M	12.69M
Free Cash Flow	-101.86M	-98.24M	-74.38M	-75.01M	-52.74M	-25.01M	-13.56M